Skip to main content

23.09.2023 | Original Paper

Influence of diabetes and obesity on ten-year outcomes after coronary artery bypass grafting in the arterial revascularisation trial

verfasst von: Maria Stefil, Mario Gaudino, Umberto Benedetto, Stephen Gerry, Alastair Gray, Belinda Lees, Bruno Podesser, Lukasz Krzych, Lokeswara Rao Sajja, David Taggart, Marcus Flather, the ART Investigators

Erschienen in: Clinical Research in Cardiology

Einloggen, um Zugang zu erhalten

Abstract

Aims

Diabetes and obesity are common conditions which can influence outcomes after coronary artery bypass graft (CABG) surgery. The aim of this study was to evaluate the influence of diabetes and obesity, and their interactions, on ten-year outcomes following CABG.

Methods and results

Patients enrolled in the Arterial Revascularisation Trial (ART) were stratified by diabetes and obesity at baseline. Diabetes was further stratified into insulin and non-insulin dependent. The primary outcome was all-cause mortality at 10 years of follow-up. Secondary outcomes were the composite of all-cause mortality, myocardial infarction or stroke at 10 years, and sternal wound complications at 6 months follow-up.
A total of 3096 patients were included in the analysis (24% with diabetes, 30% with obesity). Patients in the “diabetes/no obesity” group had a higher risk of all-cause mortality following CABG (adjusted hazard ratio [aHR] 1.33, 95% confidence interval [CI] 1.08–1.64, p = 0.01) compared to the reference group of “no diabetes/no obesity”. No excess risk was observed in the “no diabetes/obesity” or “diabetes/obesity” groups. Patients with insulin dependent diabetes had a significantly higher ten-year mortality risk compared to no diabetes (aHR 1.85, 95% CI 1.41–2.44, p = 0.00). Patients in the “diabetes/no obesity” and “diabetes/obesity groups” had a higher risk of sternal wound complications (HR 2.29, 95% CI 1.39–3.79, p < 0.001 and HR 3.21, 95% CI 1.89–5.45, p < 0.001 respectively). The composite outcome results were consistent with the mortality results.

Conclusion

Diabetes, especially insulin dependent diabetes, is associated with a higher ten-year mortality risk after CABG, in contrast to obesity which does not appear to increase long term mortality compared to non-obese. The interaction between diabetes and obesity shows an apparent “protective” effect of obesity irrespective of diabetes on mortality. Both conditions are associated with a higher risk of post-operative sternal wound infections.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat De Rosa S, Arcidiacono B, Chiefari E, Brunetti A, Indolfi C, Foti DP (2018) Type 2 diabetes mellitus and cardiovascular disease: genetic and epigenetic links. Front Endocrinol (Lausanne) 9:2CrossRefPubMed De Rosa S, Arcidiacono B, Chiefari E, Brunetti A, Indolfi C, Foti DP (2018) Type 2 diabetes mellitus and cardiovascular disease: genetic and epigenetic links. Front Endocrinol (Lausanne) 9:2CrossRefPubMed
2.
Zurück zum Zitat Riaz H, Khan MS, Siddiqi TJ, Usman MS, Shah N, Goyal A, Khan SS, Mookadam F, Krasuski RA, Ahmed H (2018) Association between obesity and cardiovascular outcomes: a systematic review and meta-analysis of mendelian randomization studies. JAMA Netw open 1:e183788CrossRefPubMedPubMedCentral Riaz H, Khan MS, Siddiqi TJ, Usman MS, Shah N, Goyal A, Khan SS, Mookadam F, Krasuski RA, Ahmed H (2018) Association between obesity and cardiovascular outcomes: a systematic review and meta-analysis of mendelian randomization studies. JAMA Netw open 1:e183788CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Neumann F-J, Sousa-Uva M, Ahlsson A et al (2019) 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J 40:87–165CrossRefPubMed Neumann F-J, Sousa-Uva M, Ahlsson A et al (2019) 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J 40:87–165CrossRefPubMed
4.
Zurück zum Zitat Fihn SD, Blankenship JC, Alexander KP et al (2014) 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, a. Circulation 130:1749–1767CrossRefPubMed Fihn SD, Blankenship JC, Alexander KP et al (2014) 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, a. Circulation 130:1749–1767CrossRefPubMed
5.
Zurück zum Zitat Head SJ, Milojevic M, Daemen J et al (2018) Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data. Lancet (London, England) 391:939–948CrossRefPubMed Head SJ, Milojevic M, Daemen J et al (2018) Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data. Lancet (London, England) 391:939–948CrossRefPubMed
6.
Zurück zum Zitat Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840–846CrossRefPubMed Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840–846CrossRefPubMed
7.
Zurück zum Zitat Eckel RH, Kahn SE, Ferrannini E et al (2011) Obesity and type 2 diabetes: what can be unified and what needs to be individualized? Diabetes Care 34:1424–1430CrossRefPubMedPubMedCentral Eckel RH, Kahn SE, Ferrannini E et al (2011) Obesity and type 2 diabetes: what can be unified and what needs to be individualized? Diabetes Care 34:1424–1430CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Kim J, Montagnani M, Koh KK, Quon MJ (2006) Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 113:1888–1904CrossRefPubMed Kim J, Montagnani M, Koh KK, Quon MJ (2006) Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 113:1888–1904CrossRefPubMed
9.
Zurück zum Zitat Piché M-E, Tchernof A, Després J-P (2020) Obesity phenotypes, diabetes, and cardiovascular diseases. Circ Res 126:1477–1500CrossRefPubMed Piché M-E, Tchernof A, Després J-P (2020) Obesity phenotypes, diabetes, and cardiovascular diseases. Circ Res 126:1477–1500CrossRefPubMed
11.
Zurück zum Zitat Ghoorah K, Campbell P, Kent A, Maznyczka A, Kunadian V (2016) Obesity and cardiovascular outcomes: a review. Eur Hear journal Acute Cardiovasc care 5:77–85CrossRef Ghoorah K, Campbell P, Kent A, Maznyczka A, Kunadian V (2016) Obesity and cardiovascular outcomes: a review. Eur Hear journal Acute Cardiovasc care 5:77–85CrossRef
12.
Zurück zum Zitat Flaherty JD, Davidson CJ (2005) Diabetes and coronary revascularization. JAMA 293:1501–1508CrossRefPubMed Flaherty JD, Davidson CJ (2005) Diabetes and coronary revascularization. JAMA 293:1501–1508CrossRefPubMed
13.
Zurück zum Zitat Simard T, Jung RG, Di Santo P et al (2021) Modifiable risk factors and residual risk following coronary revascularization. Mayo Clin Proc Innov Qual Outcomes 5:1138–1152CrossRefPubMedPubMedCentral Simard T, Jung RG, Di Santo P et al (2021) Modifiable risk factors and residual risk following coronary revascularization. Mayo Clin Proc Innov Qual Outcomes 5:1138–1152CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Taggart DP, Lees B, Gray A, Altman DG, Flather M, Channon K, ART Investigators (2006) Protocol for the Arterial Revascularisation Trial (ART). A randomised trial to compare survival following bilateral versus single internal mammary grafting in coronary revascularisation [ISRCTN46552265]. Trials 7:7 Taggart DP, Lees B, Gray A, Altman DG, Flather M, Channon K, ART Investigators (2006) Protocol for the Arterial Revascularisation Trial (ART). A randomised trial to compare survival following bilateral versus single internal mammary grafting in coronary revascularisation [ISRCTN46552265]. Trials 7:7
15.
Zurück zum Zitat Taggart DP, Altman DG, Gray AM, Lees B, Nugara F, Yu L-M, Campbell H, Flather M, Investigators ART (2010) Randomized trial to compare bilateral vs. single internal mammary coronary artery bypass grafting: 1-year results of the Arterial Revascularisation Trial (ART). Eur Heart J 31:2470–2481CrossRefPubMed Taggart DP, Altman DG, Gray AM, Lees B, Nugara F, Yu L-M, Campbell H, Flather M, Investigators ART (2010) Randomized trial to compare bilateral vs. single internal mammary coronary artery bypass grafting: 1-year results of the Arterial Revascularisation Trial (ART). Eur Heart J 31:2470–2481CrossRefPubMed
16.
Zurück zum Zitat Taggart DP, Altman DG, Gray AM, Lees B, Gerry S, Benedetto U, Flather M, Investigators ART (2016) Randomized trial of bilateral versus single internal-thoracic-artery grafts. N Engl J Med 375:2540–2549CrossRefPubMed Taggart DP, Altman DG, Gray AM, Lees B, Gerry S, Benedetto U, Flather M, Investigators ART (2016) Randomized trial of bilateral versus single internal-thoracic-artery grafts. N Engl J Med 375:2540–2549CrossRefPubMed
17.
Zurück zum Zitat Taggart DP, Benedetto U, Gerry S et al (2019) Bilateral versus single internal-thoracic-artery grafts at 10 years. N Engl J Med 380:437–446CrossRefPubMed Taggart DP, Benedetto U, Gerry S et al (2019) Bilateral versus single internal-thoracic-artery grafts at 10 years. N Engl J Med 380:437–446CrossRefPubMed
20.
Zurück zum Zitat Naito R, Miyauchi K (2017) Coronary artery disease and type 2 diabetes mellitus. Int Heart J 58:475–480CrossRefPubMed Naito R, Miyauchi K (2017) Coronary artery disease and type 2 diabetes mellitus. Int Heart J 58:475–480CrossRefPubMed
21.
Zurück zum Zitat Hegele RA (2001) Premature atherosclerosis associated with monogenic insulin resistance. Circulation 103:2225–2229CrossRefPubMed Hegele RA (2001) Premature atherosclerosis associated with monogenic insulin resistance. Circulation 103:2225–2229CrossRefPubMed
22.
Zurück zum Zitat Sato H, Carvalho G, Sato T, Lattermann R, Matsukawa T, Schricker T (2010) The association of preoperative glycemic control, intraoperative insulin sensitivity, and outcomes after cardiac surgery. J Clin Endocrinol Metab 95:4338–4344CrossRefPubMed Sato H, Carvalho G, Sato T, Lattermann R, Matsukawa T, Schricker T (2010) The association of preoperative glycemic control, intraoperative insulin sensitivity, and outcomes after cardiac surgery. J Clin Endocrinol Metab 95:4338–4344CrossRefPubMed
23.
Zurück zum Zitat Karimian N, Niculiseanu P, Amar-Zifkin A, Carli F, Feldman LS (2018) Association of elevated pre-operative hemoglobin a1c and post-operative complications in non-diabetic patients: a systematic review. World J Surg 42:61–72CrossRefPubMed Karimian N, Niculiseanu P, Amar-Zifkin A, Carli F, Feldman LS (2018) Association of elevated pre-operative hemoglobin a1c and post-operative complications in non-diabetic patients: a systematic review. World J Surg 42:61–72CrossRefPubMed
24.
Zurück zum Zitat Jahangir E, De Schutter A, Lavie CJ (2014) The relationship between obesity and coronary artery disease. Transl Res 164:336–344CrossRefPubMed Jahangir E, De Schutter A, Lavie CJ (2014) The relationship between obesity and coronary artery disease. Transl Res 164:336–344CrossRefPubMed
25.
Zurück zum Zitat Angerås O, Albertsson P, Karason K, Råmunddal T, Matejka G, James S, Lagerqvist B, Rosengren A, Omerovic E (2013) Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish coronary angiography and angioplasty registry. Eur Heart J 34:345–353CrossRefPubMed Angerås O, Albertsson P, Karason K, Råmunddal T, Matejka G, James S, Lagerqvist B, Rosengren A, Omerovic E (2013) Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish coronary angiography and angioplasty registry. Eur Heart J 34:345–353CrossRefPubMed
26.
Zurück zum Zitat Sharma A, Vallakati A, Einstein AJ, Lavie CJ, Arbab-Zadeh A, Lopez-Jimenez F, Mukherjee D, Lichstein E (2014) Relationship of body mass index with total mortality, cardiovascular mortality, and myocardial infarction after coronary revascularization: evidence from a meta-analysis. Mayo Clin Proc 89:1080–1100CrossRefPubMed Sharma A, Vallakati A, Einstein AJ, Lavie CJ, Arbab-Zadeh A, Lopez-Jimenez F, Mukherjee D, Lichstein E (2014) Relationship of body mass index with total mortality, cardiovascular mortality, and myocardial infarction after coronary revascularization: evidence from a meta-analysis. Mayo Clin Proc 89:1080–1100CrossRefPubMed
27.
Zurück zum Zitat Gurm HS, Brennan DM, Booth J, Tcheng JE, Lincoff AM, Topol EJ (2002) Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox). Am J Cardiol 90:42–45CrossRefPubMed Gurm HS, Brennan DM, Booth J, Tcheng JE, Lincoff AM, Topol EJ (2002) Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox). Am J Cardiol 90:42–45CrossRefPubMed
28.
Zurück zum Zitat Wang J, Wang C, Zeng Z, Zuo H (2022) Impact of BMI on long-term outcomes in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention. Int J Clin Pract 2022:1–8 Wang J, Wang C, Zeng Z, Zuo H (2022) Impact of BMI on long-term outcomes in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention. Int J Clin Pract 2022:1–8
30.
Zurück zum Zitat Li C, Han D, Xu F, Zheng S, Zhang L, Wang Z, Yang R, Yin H, Lyu J (2021) Obesity paradox of all-cause mortality in 4,133 patients treated with coronary revascularization. J Interv Cardiol 2021:1–10CrossRef Li C, Han D, Xu F, Zheng S, Zhang L, Wang Z, Yang R, Yin H, Lyu J (2021) Obesity paradox of all-cause mortality in 4,133 patients treated with coronary revascularization. J Interv Cardiol 2021:1–10CrossRef
31.
Zurück zum Zitat Lavie CJ, Alpert MA, Arena R, Mehra MR, Milani RV, Ventura HO (2013) Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. JACC Heart Fail 1:93–102CrossRefPubMed Lavie CJ, Alpert MA, Arena R, Mehra MR, Milani RV, Ventura HO (2013) Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. JACC Heart Fail 1:93–102CrossRefPubMed
32.
Zurück zum Zitat Alpert MA, Lavie CJ, Agrawal H, Aggarwal KB, Kumar SA (2014) Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations, and management. Transl Res 164:345–356CrossRefPubMed Alpert MA, Lavie CJ, Agrawal H, Aggarwal KB, Kumar SA (2014) Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations, and management. Transl Res 164:345–356CrossRefPubMed
33.
Zurück zum Zitat Mandviwala TM, Basra SS, Khalid U, Pickett JK, Przybylowicz R, Shah T, Nambi V, Virani SS, Deswal A (2020) Obesity and the paradox of mortality and heart failure hospitalization in heart failure with preserved ejection fraction. Int J Obes 44:1561–1567CrossRef Mandviwala TM, Basra SS, Khalid U, Pickett JK, Przybylowicz R, Shah T, Nambi V, Virani SS, Deswal A (2020) Obesity and the paradox of mortality and heart failure hospitalization in heart failure with preserved ejection fraction. Int J Obes 44:1561–1567CrossRef
35.
Zurück zum Zitat Takagi H, Umemoto T, ALICE (All-Literature Investigation of Cardiovascular Evidence) Group (2016) Overweight, but not obesity, paradox on mortality following coronary artery bypass grafting. J Cardiol 68:215–221CrossRefPubMed Takagi H, Umemoto T, ALICE (All-Literature Investigation of Cardiovascular Evidence) Group (2016) Overweight, but not obesity, paradox on mortality following coronary artery bypass grafting. J Cardiol 68:215–221CrossRefPubMed
36.
Zurück zum Zitat Hällberg V, Kataja M, Lahtela J, Tarkka M, Inamaa T, Palomäki A (2017) Obesity paradox disappears in coronary artery bypass graft patients during 20-year follow-up. Eur Hear J Acute Cardiovasc Care 6:771–777CrossRef Hällberg V, Kataja M, Lahtela J, Tarkka M, Inamaa T, Palomäki A (2017) Obesity paradox disappears in coronary artery bypass graft patients during 20-year follow-up. Eur Hear J Acute Cardiovasc Care 6:771–777CrossRef
37.
Zurück zum Zitat Benedetto U, Danese C, Codispoti M (2014) Obesity paradox in coronary artery bypass grafting: myth or reality? J Thorac Cardiovasc Surg 147:1517–1523CrossRefPubMed Benedetto U, Danese C, Codispoti M (2014) Obesity paradox in coronary artery bypass grafting: myth or reality? J Thorac Cardiovasc Surg 147:1517–1523CrossRefPubMed
38.
Zurück zum Zitat Gerich JE (2007) Type 2 diabetes mellitus is associated with multiple cardiometabolic risk factors. Clin Cornerstone 8:53–68CrossRefPubMed Gerich JE (2007) Type 2 diabetes mellitus is associated with multiple cardiometabolic risk factors. Clin Cornerstone 8:53–68CrossRefPubMed
39.
Zurück zum Zitat Tobias DK, Hu FB (2018) The association between BMI and mortality: implications for obesity prevention. Lancet Diabetes Endocrinol 6:916–917CrossRefPubMed Tobias DK, Hu FB (2018) The association between BMI and mortality: implications for obesity prevention. Lancet Diabetes Endocrinol 6:916–917CrossRefPubMed
40.
Zurück zum Zitat Sperrin M, Candlish J, Badrick E, Renehan A, Buchan I (2016) Collider bias is only a partial explanation for the obesity paradox. Epidemiology 27:525–530CrossRefPubMedPubMedCentral Sperrin M, Candlish J, Badrick E, Renehan A, Buchan I (2016) Collider bias is only a partial explanation for the obesity paradox. Epidemiology 27:525–530CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Wing RR, Lang W, Wadden TA et al (2011) Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care 34:1481–1486CrossRefPubMedPubMedCentral Wing RR, Lang W, Wadden TA et al (2011) Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care 34:1481–1486CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Ma C, Avenell A, Bolland M, Hudson J, Stewart F, Robertson C, Sharma P, Fraser C, MacLennan G (2017) Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis. BMJ 359:j4849CrossRefPubMedPubMedCentral Ma C, Avenell A, Bolland M, Hudson J, Stewart F, Robertson C, Sharma P, Fraser C, MacLennan G (2017) Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis. BMJ 359:j4849CrossRefPubMedPubMedCentral
Metadaten
Titel
Influence of diabetes and obesity on ten-year outcomes after coronary artery bypass grafting in the arterial revascularisation trial
verfasst von
Maria Stefil
Mario Gaudino
Umberto Benedetto
Stephen Gerry
Alastair Gray
Belinda Lees
Bruno Podesser
Lukasz Krzych
Lokeswara Rao Sajja
David Taggart
Marcus Flather
the ART Investigators
Publikationsdatum
23.09.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Research in Cardiology
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-023-02284-3

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.